Home

Download

Statistics

Examples

Help

Contact

	Fusion Gene Summary
	Fusion Gene ORF analysis
	Fusion Genomic Features
	Fusion Protein Features
	Fusion Gene Sequence
	Fusion Gene PPI analysis
	Related Drugs
	Related Diseases

Fusion gene:EHMT1-SPATA17 (FusionGDB2 ID:HG79813TG128153)

Fusion Gene Summary for EHMT1-SPATA17

Fusion gene summary

Fusion gene information	Fusion gene name: EHMT1-SPATA17
	Fusion gene ID: hg79813tg128153
		Hgene	Tgene
	Gene symbol	EHMT1	SPATA17
	Gene ID	79813	128153
	Gene name	euchromatic histone lysine methyltransferase 1	spermatogenesis associated 17
	Synonyms	EHMT1-IT1\|EUHMTASE1\|Eu-HMTase1\|FP13812\|GLP\|GLP1\|KLEFS1\|KMT1D	CFAP305\|FAP305\|IQCH\|MOT17\|MSRG-11\|MSRG11
	Cytomap	('EHMT1')('SPATA17') 9q34.3	1q41
	Type of gene	protein-coding	protein-coding
	Description	histone-lysine N-methyltransferase EHMT1EHMT1 intronic transcript 1G9a-like protein 1H3-K9-HMTase 5euchromatic histone-lysine N-methyltransferase 1histone H3-K9 methyltransferase 5histone-lysine N-methyltransferase, H3 lysine-9 specific 5lysine N-m	spermatogenesis-associated protein 17IQ motif containing Hspermatogenesis-related protein 11
	Modification date	20200313	20200313
	UniProtAcc	.	.
	Ensembl transtripts involved in fusion gene	ENST00000371394, ENST00000460843, ENST00000462484, ENST00000334856,
Fusion gene scores	* DoF score	15 X 9 X 8=1080	7 X 9 X 6=378
	# samples	20	7
	** MAII score	log2(20/1080*10)=-2.43295940727611 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0	log2(7/378*10)=-2.43295940727611 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0
Context	PubMed: EHMT1 [Title/Abstract] AND SPATA17 [Title/Abstract] AND fusion [Title/Abstract]
Most frequent breakpoint	EHMT1(140513501)-SPATA17(217856600), # samples:2
Anticipated loss of major functional domain due to fusion event.	EHMT1-SPATA17 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. EHMT1-SPATA17 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. EHMT1-SPATA17 seems lost the major protein functional domain in Hgene partner, which is a epigenetic factor due to the frame-shifted ORF. EHMT1-SPATA17 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF.

* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez

Partner	Gene	GO ID	GO term	PubMed ID
Hgene	EHMT1	GO:0006325	chromatin organization	12004135
Hgene	EHMT1	GO:0016571	histone methylation	12004135
Hgene	EHMT1	GO:0018027	peptidyl-lysine dimethylation	20118233

Fusion gene breakpoints across EHMT1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

Fusion gene breakpoints across SPATA17 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

Fusion gene information
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.

Source	Disease	Sample	Hgene	Hchr	Hbp	Hstrand	Tgene	Tchr	Tbp	Tstrand
ChimerDB4	OV	TCGA-24-1924-01A	EHMT1	chr9	140513501	+	SPATA17	chr1	217856600	+
ChimerDB4	OV	TCGA-24-1924-01A	EHMT1	chr9	140513501	+	SPATA17	chr1	217915317	+

Top

Fusion Gene ORF analysis for EHMT1-SPATA17

Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.

ORF	Henst	Tenst	Hgene	Hchr	Hbp	Hstrand	Tgene	Tchr	Tbp	Tstrand
3UTR-3CDS	ENST00000371394	ENST00000366933	EHMT1	chr9	140513501	+	SPATA17	chr1	217856600	+
3UTR-3CDS	ENST00000371394	ENST00000366933	EHMT1	chr9	140513501	+	SPATA17	chr1	217915317	+
3UTR-intron	ENST00000371394	ENST00000471021	EHMT1	chr9	140513501	+	SPATA17	chr1	217856600	+
3UTR-intron	ENST00000371394	ENST00000471021	EHMT1	chr9	140513501	+	SPATA17	chr1	217915317	+
5CDS-intron	ENST00000460843	ENST00000471021	EHMT1	chr9	140513501	+	SPATA17	chr1	217856600	+
5CDS-intron	ENST00000460843	ENST00000471021	EHMT1	chr9	140513501	+	SPATA17	chr1	217915317	+
5CDS-intron	ENST00000462484	ENST00000471021	EHMT1	chr9	140513501	+	SPATA17	chr1	217856600	+
5CDS-intron	ENST00000462484	ENST00000471021	EHMT1	chr9	140513501	+	SPATA17	chr1	217915317	+
5UTR-3CDS	ENST00000334856	ENST00000366933	EHMT1	chr9	140513501	+	SPATA17	chr1	217856600	+
5UTR-3CDS	ENST00000334856	ENST00000366933	EHMT1	chr9	140513501	+	SPATA17	chr1	217915317	+
5UTR-intron	ENST00000334856	ENST00000471021	EHMT1	chr9	140513501	+	SPATA17	chr1	217856600	+
5UTR-intron	ENST00000334856	ENST00000471021	EHMT1	chr9	140513501	+	SPATA17	chr1	217915317	+
Frame-shift	ENST00000460843	ENST00000366933	EHMT1	chr9	140513501	+	SPATA17	chr1	217915317	+
Frame-shift	ENST00000462484	ENST00000366933	EHMT1	chr9	140513501	+	SPATA17	chr1	217915317	+
In-frame	ENST00000460843	ENST00000366933	EHMT1	chr9	140513501	+	SPATA17	chr1	217856600	+
In-frame	ENST00000462484	ENST00000366933	EHMT1	chr9	140513501	+	SPATA17	chr1	217856600	+

ORFfinder result based on the fusion transcript sequence of in-frame fusion genes.

Henst

Tenst

Hgene

Hchr

Hbp

Hstrand

Tgene

Tchr

Tbp

Tstrand

Seq length
(transcript)

BP loci
(transcript)

Predicted start
(transcript)

Predicted stop
(transcript)

Seq length
(amino acids)

ENST00000462484

EHMT1

chr9

140513501

ENST00000366933

SPATA17

chr1

217856600

5530

852

276

ENST00000460843

EHMT1

chr9

140513501

ENST00000366933

SPATA17

chr1

217856600

5520

842

276

DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.

Henst	Tenst	Hgene	Hchr	Hbp	Hstrand	Tgene	Tchr	Tbp	Tstrand	No-coding score	Coding score
ENST00000462484	ENST00000366933	EHMT1	chr9	140513501	+	SPATA17	chr1	217856600	+	0.000715393	0.9992847
ENST00000460843	ENST00000366933	EHMT1	chr9	140513501	+	SPATA17	chr1	217856600	+	0.000716666	0.9992834

Top

Fusion Genomic Features for EHMT1-SPATA17

FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints.

Hgene	Hchr	Hbp	Hstrand	Tgene	Tchr	Tbp	Tstrand	1-p	p (fusion gene breakpoint)
EHMT1	chr9	140513501	+	SPATA17	chr1	217915316	+	2.52E-06	0.9999975
EHMT1	chr9	140513501	+	SPATA17	chr1	217856599	+	1.49E-08	1
EHMT1	chr9	140513501	+	SPATA17	chr1	217915316	+	2.52E-06	0.9999975
EHMT1	chr9	140513501	+	SPATA17	chr1	217856599	+	1.49E-08	1

Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page.

Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page.

Top

Fusion Protein Features for EHMT1-SPATA17

Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr9:140513501/chr1:217856600)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.

Main function of each fusion partner protein. (from UniProt)

Hgene	Tgene
.	.
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}.	FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}.

Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at
download page

* Minus value of BPloci means that the break pointn is located before the CDS.

- In-frame and retained protein feature among the 13 regional features.

Partner

Gene

Hbp

Tbp

ENST

Strand

BPexon

TotalExon

Protein feature loci

*BPloci

TotalLen

Protein feature

Protein feature note

- In-frame and not-retained protein feature among the 13 regional features.

Partner

Gene

Hbp

Tbp

ENST

Strand

BPexon

TotalExon

Protein feature loci

*BPloci

TotalLen

Protein feature

Protein feature note

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000334856

1292_1295

826.0

Compositional bias

Note=Poly-Ala

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000334856

406_409

826.0

Compositional bias

Note=Poly-Glu

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000334856

442_449

826.0

Compositional bias

Note=Poly-Arg

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000460843

1292_1295

1299.0

Compositional bias

Note=Poly-Ala

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000460843

406_409

1299.0

Compositional bias

Note=Poly-Glu

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000460843

442_449

1299.0

Compositional bias

Note=Poly-Arg

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000462484

1292_1295

809.0

Compositional bias

Note=Poly-Ala

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000462484

406_409

809.0

Compositional bias

Note=Poly-Glu

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000462484

442_449

809.0

Compositional bias

Note=Poly-Arg

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000334856

1060_1123

826.0

Domain

Pre-SET

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000334856

1126_1243

826.0

Domain

SET

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000460843

1060_1123

1299.0

Domain

Pre-SET

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000460843

1126_1243

1299.0

Domain

SET

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000462484

1060_1123

809.0

Domain

Pre-SET

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000462484

1126_1243

809.0

Domain

SET

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000334856

1136_1138

826.0

Region

Note=S-adenosyl-L-methionine binding

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000334856

1200_1201

826.0

Region

Note=S-adenosyl-L-methionine binding

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000334856

905_907

826.0

Region

Note=Histone H3K9me binding

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000460843

1136_1138

1299.0

Region

Note=S-adenosyl-L-methionine binding

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000460843

1200_1201

1299.0

Region

Note=S-adenosyl-L-methionine binding

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000460843

905_907

1299.0

Region

Note=Histone H3K9me binding

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000462484

1136_1138

809.0

Region

Note=S-adenosyl-L-methionine binding

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000462484

1200_1201

809.0

Region

Note=S-adenosyl-L-methionine binding

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000462484

905_907

809.0

Region

Note=Histone H3K9me binding

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000334856

737_766

826.0

Repeat

Note=ANK 1

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000334856

772_801

826.0

Repeat

Note=ANK 2

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000334856

805_834

826.0

Repeat

Note=ANK 3

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000334856

838_868

826.0

Repeat

Note=ANK 4

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000334856

872_901

826.0

Repeat

Note=ANK 5

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000334856

905_934

826.0

Repeat

Note=ANK 6

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000334856

938_967

826.0

Repeat

Note=ANK 7

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000334856

971_1004

826.0

Repeat

Note=ANK 8

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000460843

737_766

1299.0

Repeat

Note=ANK 1

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000460843

772_801

1299.0

Repeat

Note=ANK 2

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000460843

805_834

1299.0

Repeat

Note=ANK 3

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000460843

838_868

1299.0

Repeat

Note=ANK 4

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000460843

872_901

1299.0

Repeat

Note=ANK 5

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000460843

905_934

1299.0

Repeat

Note=ANK 6

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000460843

938_967

1299.0

Repeat

Note=ANK 7

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000460843

971_1004

1299.0

Repeat

Note=ANK 8

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000462484

737_766

809.0

Repeat

Note=ANK 1

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000462484

772_801

809.0

Repeat

Note=ANK 2

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000462484

805_834

809.0

Repeat

Note=ANK 3

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000462484

838_868

809.0

Repeat

Note=ANK 4

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000462484

872_901

809.0

Repeat

Note=ANK 5

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000462484

905_934

809.0

Repeat

Note=ANK 6

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000462484

938_967

809.0

Repeat

Note=ANK 7

Hgene

EHMT1

chr9:140513501

chr1:217856600

ENST00000462484

971_1004

809.0

Repeat

Note=ANK 8

Tgene

SPATA17

chr9:140513501

chr1:217856600

ENST00000366933

32_61

1879.3333333333333

Domain

IQ 1

Tgene

SPATA17

chr9:140513501

chr1:217856600

ENST00000366933

55_84

1879.3333333333333

Domain

IQ 2

Tgene

SPATA17

chr9:140513501

chr1:217856600

ENST00000366933

91_120

1879.3333333333333

Domain

IQ 3

Top

Fusion Gene Sequence for EHMT1-SPATA17

For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones.

>25589_25589_1_EHMT1-SPATA17_EHMT1_chr9_140513501_ENST00000460843_SPATA17_chr1_217856600_ENST00000366933_length(transcript)=5520nt_BP=48nt
GGCGGGGCCACGCTGCGGGCCCGGGCCATGGCCGCCGCCGATGCCGAGATTCAGAGACGATGGCGAGGCTATAGGGTTCGGAAGTACCTC
TTTAATTATTATTATTTGAAAGAGTACCTGAAAGTCGTTTCAGAGACCAATGATGCAATTAGGAAGGCACTGGAGGAGTTTGCAGAAATG
AAAGAAAGAGAAGAGAAGAAGGCTAACCTCGAAAGGGAAGAGAAGAAAAGAGATTACCAAGCCCGAAAGATGCATTACCTCCTCAGCACA
AAGCAGATTCCAGGAATATACAATTCACCCTTCAGAAAAGAGCCTGATCCATGGGAGCTGCAATTACAGAAGGCAAAGCCTTTAACACAC
CGAAGACCTAAAGTTAAGCAGAAGGACTCCACCAGCCTTACTGATTGGCTAGCTTGTACAAGCGCCCGTTCTTTTCCTCGGTCTGAAATT
CTACCACCTATTAATAGAAAGCAATGTCAGGGGCCCTTCCGAGATATCACCGAAGTATTAGAACAACGCTACAGGCCTTTGGAGCCAACG
TTGCGGGTGGCAGAACCAATCGATGAGTTAAAGTTGGCCAGAGAGGAGCTCAGAAGAGAGGAATGGCTGCAAAATGTAAATGACAATATG
TTTTTGCCATTTTCTTCATACCATAAAAATGAAAAGTACATCCCATCAATGCATTTATCAAGCAAGTATGGTCCTATTTCTTACAAAGAA
CAATTCCGAAGTGAAAATCCTAAGAAATGGATCTGTGACAAGGATTTCCAGACTGTATTACCATCATTTGAGCTCTTCTCAAAGTATGGA
AAATTATATTCAAAAGCTGGACAGATTGTATAAAGGCGTCAGAAGAAGAAACTGAAGCCATCTGCATTTTAAAACTTAACAGTTCTGAAA
GGAAAACACAGATGAAGATCCTGTAGGAAATATACTTGCTATGATTCAATAAACTATAAAATTTTGTAGCTCTAGTCATGAATTAATTAT
TGTGTGTATGTATTTGAAATCTCTTAGACATATCTTTTCAAACAAATACTTAAACTTGAGTCTGTTACCTCTGAGAATGTCTGTCACAAT
CACAGCCCCTGGTGACCAACAGTGCCATAAATGGTTCCCCTGAAATACCCATATTCTGACCCCATCACCCGGGTCACAAATGATGACACC
AGTGCTGGGTACCCAAATTAAGGGCGACTAACATGTAAGTAGGATGATGAATGGTTTGAAGTGTAAATTGTGTGAAATAGTTCAGCATGA
AAGCTCTGCCCTGAGAAATAATGACTGATTATACCAGTTAGAAACCCTTCAGACTGTTGAACTTGAGACACACAGACACAACAGACACAG
ACTAGTGGGTGTGGGAGCAGAAGCATAGGCACTCTCAAATAGAGAAGACATTTGCAAGTCTCTGCTGCCAAGGGAGCAAAGAGATAATCT
CGATGCCAGGGCTGTGTCAGATCCTGCATGGCTCTGAACTACAGTTGGTTTCCAAAAAGCTGGGCTTTTGTGAGGTTTCTGTTTTTTATG
CGATGCTTAGATTTTCCTGGAATCCTTGGAAGTTAACTCAACATTTGAGGTTCCTATATCCTTTAATCCCATCCCATGTGTATCTTTACA
ATAAAACTTCCTGCTAGAGGTATCCTGAGGGAATCTTTGTTTCTTGCATCTGAAGAGAATAACACTAAACTTATTGCATATGATTTGGGG
GTTGGATCCAATGATAGCACAGAGGGACAGGAAATGTGATTTATTGACCATAAAAGCTTTAATTTAAAATTGCTGGCCAGCGAAATCCAG
ACTCTGGGAAATGTTATAGGCCAAATGATCTGTTTCTTCAACAAATAAATTACAAAACTGAGGGGAAAAAAAGGAACCTATTAAAAAGAC
ATTATCTATCAATCACTGTGTGTGTACAGTTTTGAGCTCCTGATTTAAATAAACAAATTGTAAAATAAAAGATCTTTTGAAACAATTGGA
AGTTTGAACACTGATTGGATATTGGTGGTATAAAAGAATTATTGGTTTTTTTTAGGTGTCATGGTATTGTTTTGGTTTACAAAGTTATAG
ATATAAATGTTGAAATATTTACAGATGCAGTGATATGTTGGCTGGGATTTAATTTGAAAGTCAAAGAAGTGAGTTAAAATACATATACTC
CTCCTCTTATAATCGGTTATGTGCCAATAAATCCATTGTAAATTGAAAATATCCTAAGTTGAAAATATTGTAAGTTAAAAATGCATTTAA
TACAGCTAACTTACCAGACAGCTTAGCTTAGCCTCACCTACCTTAAATATGCTCAGAACACATACGTTAGCCTATAGTTGGGCAAAATCA
TCTAACACAAAGCCTATTTTATAATATTGAACAGCCCATGTAATTTATTGAATATTGTACTAAAAGTGAAAAACTGAATAGTTGTATGCA
TACTCAAAGTATGGTTTCTACTGAATGCATTGTAAACCAGAAAGTATCTGAGACAATGTTTTTTTTTTTTTTTTTTTTTTTTTTAATTTC
TGAGACAGAGTCTCATTCTGTCACCCAGGTTGGAGTGCAGTGGCATGAACTCAGCTCACTGCAACCTTCACCTCCCAGGCTCAAGCAGTC
CTCCCATCTCAGCCTCCCAAGTAGCTGGGACCACAGGCATGGGCCAACAAGCCTGGCTAAATATTTTGTACTTTTGGTAGACACGGGTTT
TTACCATGTTGTGCAGGCTGGTCTTGAACGCCTGAGCTCAAGTGATCTGCCTGCCTCGGCCTCCCAAAGTACTGGGATTACAGGCATGAG
TCACTGAACCCAGCCCTGAGACATGTCTCAATTAGTTTAGAAGTTTATTTGGCCAAGGTTAAGGACATGCCCTTGACACTGCACCTGTCA
GTACAGGTCCTGACAACATGTGTCCAAGGTGGTCAAGCTATACAACTTGGTTTTATACATTTTAAGGAGACATAAGACATCAATAAATAC
ATGGAAGATGTACATTGGTTCAGTCTGGAAAGGCAGGATGCCTCAAACTTGAAACAAGAGAATGGGGGGTGGGAGGATGTGGGAGATGCT
TCCAGGTCATAGTTGGAGTCAAAGACTTTCCAATTGGCAATTGGTTCAAAGAATTTATCTAAAGACCTGGAATCCATAGAAGGCTTTACC
TGGATTAAAATAAGGGGACCAAGGTTCTCATGCAGATGAAGCCTCCAGGTGGCAGACTTCAGAGAGCATAGATTGTAAATGTTTCTTATC
TGACTTAAAAAGGTGTCAGACTCTTAGTAAATTATCTCCTGGATCAGTGAAAAGATGTGAAAAAAGGTTCTCTACAGAATGTAGATTTTC
CCCATAAGAGATAGCTTCGCAGGGCCATTGCAAAATATGTCAAAAATATATATTTTAGGGTAAAATGCCTCAATTTATTTCAAGGCCTGA
TATTTGTCATGTGATGCTATACTACAGTCAGGCTGAAACTTGGCATCTTATTGCTATGAAAAATCTTAAGATCTCTATTTTAATGTTAAT
GCTGGTCACTGGTGCCTGAATTCCAAAGGGAGGAGGGTATAATGAAGCATGTCCAATTCCCCATGCCCCACCCCCACCCCCACATCCTAT
AATGGCCTGAACTAGTTTTTCAGGTTAACTTTGGAATACCCTTGGCCAAGAAGAGGGGTCCATGCAGATGTTTGGAGGGGGGGGTCTTAA
AGCTTTATTTTTAGATTACAGCATATTGCTTTTGCACTATCATAAAGTAAAAACATCATAAGTCAAGCCACCATAAATAGCGGACCATCT
GTATATCTGAAAGAAGATGAACCAAGACTTGGTTATTGTTAAAGCTGATGATTGGCTGTATGAAGATTTACTATACAATTTTGTGTACTT
TTGTAAGTTCTTGGTTGTTTCTAAACTTATAACAAAATAAATAATTGGCCATCTTCATTGGATTGTGAAGCCATTTCCTCCCACATGTTC
GTAAAAATGGTAGCCATGGCCCCTGACTGAACCCAGGTATGAATGGCCTTCATTGATTTTGTAGACCCTGACCTTCTCTGTTCTTCCAGA
GAAGGTGGTACTCAGATAAAAACTTTGAAGCATTTTATTGTTCAGAATATGACTTTGATCTTCTCATAAGACTCAAGTTTTTGAATGCTT
AAGGCTCTTTATCGCTAGTGTATGTAAGTAATATCATTGTCCTTAACCACCATCTGCCTCTCCCCCCAGACACACATAAGTTTATGATAA
CTACAGAGGTGTCCAGATGAGTAAAAACTGCCTTTGCATTAAGGTGAGAGAAGACCGAGATGAAATCTTATTAGAAAATATAACTGGGGA
AAGCAGTTTGTCTGTTTCTCCTGGAAAACTACTAGACTACATCAACTTATATACTACTTCTTTTCTATATTCTCAATATGAGCCACTTAA
GAAAATTAATGAGACTTTATGTTTGACCAAAGCTGGTAATTCCTTGATCTTATTCTCCAAACTTGATTCTGAATGACTACTGACCACTAA
AAACACTAAGAGTACCACTGTGGATGTTTAAAAACATACACCCTAAGAGCCTTCAGAATTAGACGCTTCAATTCTTCTGAAATCAAAAGT
CACACCAGCTTTGCTGTAGTTAATCAGGTAATACCTTTCTTCTCCACTACTCTCTAATTTCCTTGAGGGCAAATATTGTCTTTCTTGATA
AATGCCCTGGACCCAACATCTAACAGAATACCTGGCATAAAGTGAAATCCATCGAATGTGCTAATGATAAATAAAGAAGTTCAAAAAAAT
CTTTTAATAGAAGCTATAAAATAGCAGATAAGCTAAGTCATTCTCATAAAACACCATTTGTCATTTGAATGCGTGCATTGTGGCCTGTTA
CTTTTAACTAGTCTCACTAATTTATAGTTATATATGATGTAGATCTAGATTGTGATGTACACTAAGTGGGTTGATCCTGAGATCAAGCTA
TGATTGCTGCTTGCGTAAAGTGTTCCTTTTGGGAAATAAATAATCTTTCATATCTGTAAACTTTGGTATAATTGGTTATTTATGCAATGT
ATTGTTGTGGTTGTCAACTCAAGATTGTATTCTCATCTGGGGACATTATGAATCTTGTTATTTTATCCCCTTTTTTGCTCTGTTTTTTCA
CATTTATGGCCTACCTGTTACAGCTGCACGGTATCCATTTTCTGTGCTAAATTCATCTTTAATTTATTATTTTTTTTCAACCTCAGCTTT
TAACTTTGCCCTGATTTTCTCTTCCATTTTATTTTCACTTCCATTTTAAGCTGGCTCAAAGCCTTTTAGGAACAATAAGTTACTGAATTA
TATGAACCTATTTGAGGTAATGATGATGCCTGGGAAGGAGCAGTATTGCTGGATCAGAATTCACTTTTTCCAAGTTACAGATTTTAATAA
ACCACTGTGCAAAGCATTAGGATAAATTTTTATTGAAAATTGAGTGAATGACTGAACAAATCGCTGGGTAATGCTGTTTAGGTTGTTCTA
TTTTCCACGGATTAAATTAAATTCTATGTA

>25589_25589_1_EHMT1-SPATA17_EHMT1_chr9_140513501_ENST00000460843_SPATA17_chr1_217856600_ENST00000366933_length(amino acids)=276AA_BP=12
MRARAMAAADAEIQRRWRGYRVRKYLFNYYYLKEYLKVVSETNDAIRKALEEFAEMKEREEKKANLEREEKKRDYQARKMHYLLSTKQIP
GIYNSPFRKEPDPWELQLQKAKPLTHRRPKVKQKDSTSLTDWLACTSARSFPRSEILPPINRKQCQGPFRDITEVLEQRYRPLEPTLRVA
EPIDELKLAREELRREEWLQNVNDNMFLPFSSYHKNEKYIPSMHLSSKYGPISYKEQFRSENPKKWICDKDFQTVLPSFELFSKYGKLYS
KAGQIV

--------------------------------------------------------------
>25589_25589_2_EHMT1-SPATA17_EHMT1_chr9_140513501_ENST00000462484_SPATA17_chr1_217856600_ENST00000366933_length(transcript)=5530nt_BP=58nt
GCGCGGGAGGGGCGGGGCCACGCTGCGGGCCCGGGCCATGGCCGCCGCCGATGCCGAGATTCAGAGACGATGGCGAGGCTATAGGGTTCG
GAAGTACCTCTTTAATTATTATTATTTGAAAGAGTACCTGAAAGTCGTTTCAGAGACCAATGATGCAATTAGGAAGGCACTGGAGGAGTT
TGCAGAAATGAAAGAAAGAGAAGAGAAGAAGGCTAACCTCGAAAGGGAAGAGAAGAAAAGAGATTACCAAGCCCGAAAGATGCATTACCT
CCTCAGCACAAAGCAGATTCCAGGAATATACAATTCACCCTTCAGAAAAGAGCCTGATCCATGGGAGCTGCAATTACAGAAGGCAAAGCC
TTTAACACACCGAAGACCTAAAGTTAAGCAGAAGGACTCCACCAGCCTTACTGATTGGCTAGCTTGTACAAGCGCCCGTTCTTTTCCTCG
GTCTGAAATTCTACCACCTATTAATAGAAAGCAATGTCAGGGGCCCTTCCGAGATATCACCGAAGTATTAGAACAACGCTACAGGCCTTT
GGAGCCAACGTTGCGGGTGGCAGAACCAATCGATGAGTTAAAGTTGGCCAGAGAGGAGCTCAGAAGAGAGGAATGGCTGCAAAATGTAAA
TGACAATATGTTTTTGCCATTTTCTTCATACCATAAAAATGAAAAGTACATCCCATCAATGCATTTATCAAGCAAGTATGGTCCTATTTC
TTACAAAGAACAATTCCGAAGTGAAAATCCTAAGAAATGGATCTGTGACAAGGATTTCCAGACTGTATTACCATCATTTGAGCTCTTCTC
AAAGTATGGAAAATTATATTCAAAAGCTGGACAGATTGTATAAAGGCGTCAGAAGAAGAAACTGAAGCCATCTGCATTTTAAAACTTAAC
AGTTCTGAAAGGAAAACACAGATGAAGATCCTGTAGGAAATATACTTGCTATGATTCAATAAACTATAAAATTTTGTAGCTCTAGTCATG
AATTAATTATTGTGTGTATGTATTTGAAATCTCTTAGACATATCTTTTCAAACAAATACTTAAACTTGAGTCTGTTACCTCTGAGAATGT
CTGTCACAATCACAGCCCCTGGTGACCAACAGTGCCATAAATGGTTCCCCTGAAATACCCATATTCTGACCCCATCACCCGGGTCACAAA
TGATGACACCAGTGCTGGGTACCCAAATTAAGGGCGACTAACATGTAAGTAGGATGATGAATGGTTTGAAGTGTAAATTGTGTGAAATAG
TTCAGCATGAAAGCTCTGCCCTGAGAAATAATGACTGATTATACCAGTTAGAAACCCTTCAGACTGTTGAACTTGAGACACACAGACACA
ACAGACACAGACTAGTGGGTGTGGGAGCAGAAGCATAGGCACTCTCAAATAGAGAAGACATTTGCAAGTCTCTGCTGCCAAGGGAGCAAA
GAGATAATCTCGATGCCAGGGCTGTGTCAGATCCTGCATGGCTCTGAACTACAGTTGGTTTCCAAAAAGCTGGGCTTTTGTGAGGTTTCT
GTTTTTTATGCGATGCTTAGATTTTCCTGGAATCCTTGGAAGTTAACTCAACATTTGAGGTTCCTATATCCTTTAATCCCATCCCATGTG
TATCTTTACAATAAAACTTCCTGCTAGAGGTATCCTGAGGGAATCTTTGTTTCTTGCATCTGAAGAGAATAACACTAAACTTATTGCATA
TGATTTGGGGGTTGGATCCAATGATAGCACAGAGGGACAGGAAATGTGATTTATTGACCATAAAAGCTTTAATTTAAAATTGCTGGCCAG
CGAAATCCAGACTCTGGGAAATGTTATAGGCCAAATGATCTGTTTCTTCAACAAATAAATTACAAAACTGAGGGGAAAAAAAGGAACCTA
TTAAAAAGACATTATCTATCAATCACTGTGTGTGTACAGTTTTGAGCTCCTGATTTAAATAAACAAATTGTAAAATAAAAGATCTTTTGA
AACAATTGGAAGTTTGAACACTGATTGGATATTGGTGGTATAAAAGAATTATTGGTTTTTTTTAGGTGTCATGGTATTGTTTTGGTTTAC
AAAGTTATAGATATAAATGTTGAAATATTTACAGATGCAGTGATATGTTGGCTGGGATTTAATTTGAAAGTCAAAGAAGTGAGTTAAAAT
ACATATACTCCTCCTCTTATAATCGGTTATGTGCCAATAAATCCATTGTAAATTGAAAATATCCTAAGTTGAAAATATTGTAAGTTAAAA
ATGCATTTAATACAGCTAACTTACCAGACAGCTTAGCTTAGCCTCACCTACCTTAAATATGCTCAGAACACATACGTTAGCCTATAGTTG
GGCAAAATCATCTAACACAAAGCCTATTTTATAATATTGAACAGCCCATGTAATTTATTGAATATTGTACTAAAAGTGAAAAACTGAATA
GTTGTATGCATACTCAAAGTATGGTTTCTACTGAATGCATTGTAAACCAGAAAGTATCTGAGACAATGTTTTTTTTTTTTTTTTTTTTTT
TTTTAATTTCTGAGACAGAGTCTCATTCTGTCACCCAGGTTGGAGTGCAGTGGCATGAACTCAGCTCACTGCAACCTTCACCTCCCAGGC
TCAAGCAGTCCTCCCATCTCAGCCTCCCAAGTAGCTGGGACCACAGGCATGGGCCAACAAGCCTGGCTAAATATTTTGTACTTTTGGTAG
ACACGGGTTTTTACCATGTTGTGCAGGCTGGTCTTGAACGCCTGAGCTCAAGTGATCTGCCTGCCTCGGCCTCCCAAAGTACTGGGATTA
CAGGCATGAGTCACTGAACCCAGCCCTGAGACATGTCTCAATTAGTTTAGAAGTTTATTTGGCCAAGGTTAAGGACATGCCCTTGACACT
GCACCTGTCAGTACAGGTCCTGACAACATGTGTCCAAGGTGGTCAAGCTATACAACTTGGTTTTATACATTTTAAGGAGACATAAGACAT
CAATAAATACATGGAAGATGTACATTGGTTCAGTCTGGAAAGGCAGGATGCCTCAAACTTGAAACAAGAGAATGGGGGGTGGGAGGATGT
GGGAGATGCTTCCAGGTCATAGTTGGAGTCAAAGACTTTCCAATTGGCAATTGGTTCAAAGAATTTATCTAAAGACCTGGAATCCATAGA
AGGCTTTACCTGGATTAAAATAAGGGGACCAAGGTTCTCATGCAGATGAAGCCTCCAGGTGGCAGACTTCAGAGAGCATAGATTGTAAAT
GTTTCTTATCTGACTTAAAAAGGTGTCAGACTCTTAGTAAATTATCTCCTGGATCAGTGAAAAGATGTGAAAAAAGGTTCTCTACAGAAT
GTAGATTTTCCCCATAAGAGATAGCTTCGCAGGGCCATTGCAAAATATGTCAAAAATATATATTTTAGGGTAAAATGCCTCAATTTATTT
CAAGGCCTGATATTTGTCATGTGATGCTATACTACAGTCAGGCTGAAACTTGGCATCTTATTGCTATGAAAAATCTTAAGATCTCTATTT
TAATGTTAATGCTGGTCACTGGTGCCTGAATTCCAAAGGGAGGAGGGTATAATGAAGCATGTCCAATTCCCCATGCCCCACCCCCACCCC
CACATCCTATAATGGCCTGAACTAGTTTTTCAGGTTAACTTTGGAATACCCTTGGCCAAGAAGAGGGGTCCATGCAGATGTTTGGAGGGG
GGGGTCTTAAAGCTTTATTTTTAGATTACAGCATATTGCTTTTGCACTATCATAAAGTAAAAACATCATAAGTCAAGCCACCATAAATAG
CGGACCATCTGTATATCTGAAAGAAGATGAACCAAGACTTGGTTATTGTTAAAGCTGATGATTGGCTGTATGAAGATTTACTATACAATT
TTGTGTACTTTTGTAAGTTCTTGGTTGTTTCTAAACTTATAACAAAATAAATAATTGGCCATCTTCATTGGATTGTGAAGCCATTTCCTC
CCACATGTTCGTAAAAATGGTAGCCATGGCCCCTGACTGAACCCAGGTATGAATGGCCTTCATTGATTTTGTAGACCCTGACCTTCTCTG
TTCTTCCAGAGAAGGTGGTACTCAGATAAAAACTTTGAAGCATTTTATTGTTCAGAATATGACTTTGATCTTCTCATAAGACTCAAGTTT
TTGAATGCTTAAGGCTCTTTATCGCTAGTGTATGTAAGTAATATCATTGTCCTTAACCACCATCTGCCTCTCCCCCCAGACACACATAAG
TTTATGATAACTACAGAGGTGTCCAGATGAGTAAAAACTGCCTTTGCATTAAGGTGAGAGAAGACCGAGATGAAATCTTATTAGAAAATA
TAACTGGGGAAAGCAGTTTGTCTGTTTCTCCTGGAAAACTACTAGACTACATCAACTTATATACTACTTCTTTTCTATATTCTCAATATG
AGCCACTTAAGAAAATTAATGAGACTTTATGTTTGACCAAAGCTGGTAATTCCTTGATCTTATTCTCCAAACTTGATTCTGAATGACTAC
TGACCACTAAAAACACTAAGAGTACCACTGTGGATGTTTAAAAACATACACCCTAAGAGCCTTCAGAATTAGACGCTTCAATTCTTCTGA
AATCAAAAGTCACACCAGCTTTGCTGTAGTTAATCAGGTAATACCTTTCTTCTCCACTACTCTCTAATTTCCTTGAGGGCAAATATTGTC
TTTCTTGATAAATGCCCTGGACCCAACATCTAACAGAATACCTGGCATAAAGTGAAATCCATCGAATGTGCTAATGATAAATAAAGAAGT
TCAAAAAAATCTTTTAATAGAAGCTATAAAATAGCAGATAAGCTAAGTCATTCTCATAAAACACCATTTGTCATTTGAATGCGTGCATTG
TGGCCTGTTACTTTTAACTAGTCTCACTAATTTATAGTTATATATGATGTAGATCTAGATTGTGATGTACACTAAGTGGGTTGATCCTGA
GATCAAGCTATGATTGCTGCTTGCGTAAAGTGTTCCTTTTGGGAAATAAATAATCTTTCATATCTGTAAACTTTGGTATAATTGGTTATT
TATGCAATGTATTGTTGTGGTTGTCAACTCAAGATTGTATTCTCATCTGGGGACATTATGAATCTTGTTATTTTATCCCCTTTTTTGCTC
TGTTTTTTCACATTTATGGCCTACCTGTTACAGCTGCACGGTATCCATTTTCTGTGCTAAATTCATCTTTAATTTATTATTTTTTTTCAA
CCTCAGCTTTTAACTTTGCCCTGATTTTCTCTTCCATTTTATTTTCACTTCCATTTTAAGCTGGCTCAAAGCCTTTTAGGAACAATAAGT
TACTGAATTATATGAACCTATTTGAGGTAATGATGATGCCTGGGAAGGAGCAGTATTGCTGGATCAGAATTCACTTTTTCCAAGTTACAG
ATTTTAATAAACCACTGTGCAAAGCATTAGGATAAATTTTTATTGAAAATTGAGTGAATGACTGAACAAATCGCTGGGTAATGCTGTTTA
GGTTGTTCTATTTTCCACGGATTAAATTAAATTCTATGTA

>25589_25589_2_EHMT1-SPATA17_EHMT1_chr9_140513501_ENST00000462484_SPATA17_chr1_217856600_ENST00000366933_length(amino acids)=276AA_BP=12
MRARAMAAADAEIQRRWRGYRVRKYLFNYYYLKEYLKVVSETNDAIRKALEEFAEMKEREEKKANLEREEKKRDYQARKMHYLLSTKQIP
GIYNSPFRKEPDPWELQLQKAKPLTHRRPKVKQKDSTSLTDWLACTSARSFPRSEILPPINRKQCQGPFRDITEVLEQRYRPLEPTLRVA
EPIDELKLAREELRREEWLQNVNDNMFLPFSSYHKNEKYIPSMHLSSKYGPISYKEQFRSENPKKWICDKDFQTVLPSFELFSKYGKLYS
KAGQIV

--------------------------------------------------------------

Top

Fusion Gene PPI Analysis for EHMT1-SPATA17

Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in
ChiPPI page.

Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)

Hgene

Hgene's interactors

Tgene

Tgene's interactors

- Retained PPIs in in-frame fusion.

Partner

Gene

Hbp

Tbp

ENST

Strand

BPexon

TotalExon

Protein feature loci

*BPloci

TotalLen

Still interaction with

- Lost PPIs in in-frame fusion.

Partner	Gene	Hbp	Tbp	ENST	Strand	BPexon	TotalExon	Protein feature loci	*BPloci	TotalLen	Interaction lost with
Hgene	EHMT1	chr9:140513501	chr1:217856600	ENST00000334856	+	1	17	1162_1181	0	826.0	histone H3
Hgene	EHMT1	chr9:140513501	chr1:217856600	ENST00000334856	+	1	17	1242_1245	0	826.0	histone H3
Hgene	EHMT1	chr9:140513501	chr1:217856600	ENST00000460843	+	1	27	1162_1181	7.0	1299.0	histone H3
Hgene	EHMT1	chr9:140513501	chr1:217856600	ENST00000460843	+	1	27	1242_1245	7.0	1299.0	histone H3
Hgene	EHMT1	chr9:140513501	chr1:217856600	ENST00000462484	+	1	16	1162_1181	7.0	809.0	histone H3
Hgene	EHMT1	chr9:140513501	chr1:217856600	ENST00000462484	+	1	16	1242_1245	7.0	809.0	histone H3

- Retained PPIs, but lost function due to frame-shift fusion.

Partner

Gene

Hbp

Tbp

ENST

Strand

BPexon

TotalExon

Protein feature loci

*BPloci

TotalLen

Interaction lost with

Top

Related Drugs for EHMT1-SPATA17

Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.8 2021-05-08)

Partner

Gene

UniProtAcc

DrugBank ID

Drug name

Drug activity

Drug type

Drug status

Top

Related Diseases for EHMT1-SPATA17

Diseases associated with fusion partners.
(DisGeNet 4.0)

Partner	Gene	Disease ID	Disease name	# pubmeds	Source
Hgene	EHMT1	C0795833	KLEEFSTRA SYNDROME 1	11	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
Hgene	EHMT1	C0025149	Medulloblastoma	1	CTD_human
Hgene	EHMT1	C0205833	Medullomyoblastoma	1	CTD_human
Hgene	EHMT1	C0278510	Childhood Medulloblastoma	1	CTD_human
Hgene	EHMT1	C0278876	Adult Medulloblastoma	1	CTD_human
Hgene	EHMT1	C0751291	Desmoplastic Medulloblastoma	1	CTD_human
Hgene	EHMT1	C1275668	Melanotic medulloblastoma	1	CTD_human

Fusion Gene Studies in Kim Lab

Fusion gene:EHMT1-SPATA17 (FusionGDB2 ID:HG79813TG128153)

Fusion Gene Summary for EHMT1-SPATA17

Fusion Gene ORF analysis for EHMT1-SPATA17

Fusion Genomic Features for EHMT1-SPATA17

Fusion Protein Features for EHMT1-SPATA17

Fusion Gene Sequence for EHMT1-SPATA17

Fusion Gene PPI Analysis for EHMT1-SPATA17

Related Drugs for EHMT1-SPATA17

Related Diseases for EHMT1-SPATA17

Fusion Gene Studies
in Kim Lab